TrialLancet (London, England)2020
Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial.
John Burn et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
230 papers cite itlatest 60 shown
this paperpooled ittrialcites it